A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma
Clinical trial NCT02554786 · COMPLETED
Trial details
- NCT number
- NCT02554786
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-29
- Primary completion
- 2018-11-21
- Enrollment
- 2216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.